InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update
JENA, Germany, Nov. 01, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today financial results for the three and nine months ended September 30, 2023, and provided an operating update.
Related news for (IFRX)
- Breaking News: MoBot’s Latest Update as of 08/29/25 07:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/29/25 06:00 PM
- MoBot alert highlights: NASDAQ: IFRX, NASDAQ: CARM, NASDAQ: ULCC, NASDAQ: HWH, NASDAQ: KAVL (08/29/25 05:00 PM)
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/29/25 01:00 PM
- Breaking News: MoBot’s Latest Update as of 08/29/25 12:00 PM
